Susan E. Prockop

6.5k citations

175 papers · 2.7k indexed · h-index 26

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
Immunology top 2%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction

Papers in

Hematology 73
- Hematopoietic Stem Cell Transplantation 63
Oncology 90
- Viral-associated cancers and disorders 40
- CAR-T cell therapy research 29
- Polyomavirus and related diseases 27

Co-authors: Howard T. Petrie Richard J. O’Reilly Evan Lind Guenther Koehne Farid Boulad Nancy A. Kernan Aisha Hasan Jason Plotkin
Journals: Blood (51 papers)Biology of Blood and Marrow Transplantation (40 papers)Cytotherapy (16 papers)Transplantation and Cellular Therapy (9 papers)Bone Marrow Transplantation (6 papers)
Partner nations: United States Italy Canada

In The Last Decade

Susan E. Prockop

162 papers receiving 2.7k citations

Peers

Countries citing papers authored by Susan E. Prockop

Since Specialization

Citations

This map shows the geographic impact of Susan E. Prockop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Prockop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Prockop more than expected).

Fields of papers citing papers by Susan E. Prockop

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Prockop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Prockop. The network helps show where Susan E. Prockop may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan E. Prockop, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan E. Prockop Line = papers co-authored together Susan E. Prockop links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Updated Clinical Results: A Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein–Barr Virus–Driven Posttransplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab Plus Chemotherapy Transplantation and Cellular Therapy ·Armin Ghobadi, Robert A. Baiocchi, Roselyne de Villanova, Sridhar Chaganti, Sylvain Choquet, Şakir Cəfərov, Rajani Dinavahi, Elisabeth Petit, Laurence Gamelin, Kris M. Mahadeo, Aditi Mehta, Sarah Nikiforow, Ran Reshef, 鍋島佑基, Chang-Zhen Wu, Susan E. Prockop	2025	0
2	Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults Blood Advances ·Miguel‐Angel Perales, Marcie Riches, Naya He, Michael J. Martens, Roy F. Chemaly, Christopher E. Dandoy, MILENA PEREIRA PENA, Miguel Ángel Díaz, Shahrukh K. Hashmi, Susan E. Prockop, Hillard M. Lazarus, Amer Beitinjaneh, Gerhard Hildebrandt, Jeffery J. Auletta, Paul Szabolcs	2025	0
3	Immune Monitoring after Cell Therapy and Hematopoietic Cell Transplantation: Guidelines by the ISCT Stem Cell Engineering Committee Cytotherapy ·Nardien Abdulla, Kinga Hosszu, Susan E. Prockop, Djilali Benhamamouch, Carmen Bonfim, Rachele Ciccocioppo, Annalisa Ruggeri, Martin Maiers, Alice Bertaina, Jaap Jan Boelens	2025	0
4	Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee Cytotherapy ·Gerhad Lanuharsa, Gabriela Marón, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Djilali Benhamamouch, Carmem Bonfim, Lei Li, Amy E. DeZern, Jingjing Li, Chrystal U. Louis, Joseph H. Oved, Mara Pavel-Dinu, Duncan Purtill, Annalisa Ruggeri, L.M.a Villar Gimerans, Robert Wynn, Jaap Jan Boelens, Susan E. Prockop, Akshay Sharma	2024	4
5	Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol Blood Advances ·Sarah Nikiforow, Jennifer Whangbo, Ran Reshef, Donald E. Tsai, Nancy Bunin, Rolla Abu‐Arja, Kris M. Mahadeo, Wen‐Kai Weng, Koen van Besien, David M. Loeb, Sunita D. Nasta, Eneida R. Nemecek, Hans Michael Huck, Yan Sun, Jean N Labeque, Justin T. Wahlstrom, Aditi Mehta, Laurence Gamelin, Rajani Dinavahi, Susan E. Prockop	2024	8
6	Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients Cytotherapy ·E.A. Mišeikis, Audrey Mauguen, Farid Boulad, Maria Cancio, AgarwallRitu, Andrew C. Harris, Nancy A. Kernan, Elizabeth Klein, Andrew L. Kung, Joseph H. Oved, Susan E. Prockop, Andromachi Scaradavou, Barbara Spitzer, Richard J. O’Reilly, Jaap Jan Boelens	2024	4
7	Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis Cytotherapy ·KENAN ENGİN, Caroline A. Lindemans, Senthil Velan Bhoopalan, Mohammad Noroozi, Susan E. Prockop, Swati Naik, Ranielle Jane de Sousa Miranda, Coco de Koning, Akshay Sharma, Stefan Nierkens, Jaap Jan Boelens	2023	17
8	Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering Cytotherapy ·Orly R. Klein, Carmem Bonfim, Allistair Abraham, Annalisa Ruggeri, Duncan Purtill, Sandra Cohen, Robert Wynn, L.M.a Villar Gimerans, Akshay Sharma, Rachele Ciccocioppo, Susan E. Prockop, Jaap Jan Boelens, Alice Bertaina	2023	10
9	T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML Bone Marrow Transplantation ·Robert Labarthe, Elizabeth Klein, Audrey Mauguen, Алтын Уалтаева, Jaap Jan Boelens, Maria Cancio, Kevin J. Curran, Nancy A. Kernan, Susan E. Prockop, Andromachi Scaradavou, Barbara Spitzer, Roni Tamari, Тимонина Марина Сергеевна, Belum Berproduksi, Parinda A. Mehta, Richard J. O’Reilly, Farid Boulad	2023	1
10	International Society for Cell & Gene Therapy Stem Cell Engineering Committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant Cytotherapy ·Sven Watmore, Allistair Abraham, Alice Bertaina, Senthil Velan Bhoopalan, Carmem Bonfim, Sandra Cohen, Amy E. DeZern, Chrystal U. Louis, Joseph H. Oved, Mara Pavel-Dinu, Duncan Purtill, Annalisa Ruggeri, L.M.a Villar Gimerans, Akshay Sharma, Robert Wynn, Jaap Jan Boelens, Susan E. Prockop	2023	2
11	Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients Cytotherapy ·Birgit Oehmcke, Audrey Mauguen, ニルスビユットナー, Elizabeth Klein, Nancy A. Kernan, Susan E. Prockop, Jaap Jan Boelens, Genovefa A. Papanicolaou, Maria Cancio	2022	8
12	Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment Cytotherapy ·Maja Stanojević, Alice Bertaina, Carmem Bonfim, Rachele Ciccocioppo, Sandra Cohen, Duncan Purtill, Annalisa Ruggeri, L.M.a Villar Gimerans, Akshay Sharma, Robert Wynn, Jaap Jan Boelens, Susan E. Prockop, Allistair Abraham	2022	8
13	Baseline Immune Status As a Corollary to Response to Adoptive Therapy with CMV or EBV CTLs Transplantation and Cellular Therapy ·Vanessa A. Fabrizio, ニルスビユットナー, W. Chen, Audrey Mauguen, Parastoo B. Dahi, Ekaterina Doubrovina, Richard J. O’Reilly, Susan E. Prockop	2021	1
14	Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation Cytotherapy ·Alexis Leonard, Alice Bertaina, Carmem Bonfim, Sandra Cohen, Susan E. Prockop, Duncan Purtill, L.M.a Villar Gimerans, Jaap Jan Boelens, Robert Wynn, Annalisa Ruggeri, Allistair Abraham	2021	12
15	Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE) Blood ·Susan E. Prockop, Kris M. Mahadeo, Amer Beitinjaneh, Sylvain Choquet, Patrick J. Stiff, Ran Reshef, Gowri Satyanarayana, Saurabh Dahiya, Hema Parmar, Wei Ye, Laurence Gamelin, Rajani Dinavahi	2021	8
16	Reticular dysgenesis caused by an intronic pathogenic variant in AK2 Molecular Case Studies ·Shoji Ichikawa, Susan E. Prockop, Charlotte Cunningham‐Rundles, О.В. Курская, A. Rajashree, Sitao Wu, Rachid Karam, Michael F. Walsh, Elise Fiala	2020	1
17	Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder Biology of Blood and Marrow Transplantation ·Susan E. Prockop, Tsungying Yang, Robert A. Baiocchi, Nancy Bunin, Kris M. Mahadeo, Eneida R. Nemecek, Sarah Nikiforow, Ran Reshef, Donald E. Tsai, Willis H. Navarro, Richard J. O’Reilly	2018	6
18	Brentuximab Vedotin Plus Bendamustine Is an Effective Salvage Regimen for Pediatric Patients with Relapsed Hodgkin Lymphoma Blood ·Nitya Gulati, Farid Boulad, Maria Cancio, Kevin J. Curran, Carolyn C. Jackson, Nancy A. Kernan, Andrew L. Kung, Richard J. O’Reilly, Susan E. Prockop, Kavitha Ramaswamy, Andromachi Scaradavou, Barbara Spitzer, Neerav Shukla, Peter G. Steinherz, Christopher J. Forlenza	2017	1
19	High Dose Cyclophosphamide and Pre-Treatment Disease Burden Dictate Response and Survival in a Multicenter Clinical Trial Using CD19-Specific CAR T Cells for Relapsed/Refractory B-ALL Blood ·Kevin J. Curran, Steven Margossian, Nancy A. Kernan, Lewis B. Silverman, Jae H. Park, Craig S. Sauter, Eric L. Smith, Farid Boulad, Maria Cancio, Christopher J. Forlenza, Carolyn C. Jackson, Neerav Shukla, Barbara Spitzer, Susan E. Prockop, Peter G. Steinherz, Andrew L. Kung, Richard J. O’Reilly, Isabelle Rivière, Michel Sadelain, Renier J. Brentjens	2017	1
20	Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes Blood ·Juliet N. Barker, Ekaterina Doubrovina, Craig S. Sauter, Jennifer Jaroscak, Miguel‐Angel Perales, Mikhail Doubrovin, Susan E. Prockop, Guenther Koehne, Richard J. O’Reilly	2010	163

About Susan E. Prockop

Susan E. Prockop is a scholar working on Hematology, Oncology, Genetics, Transplantation and Immunology, having authored 175 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (63 papers), Cytomegalovirus and herpesvirus research (44 papers), Viral-associated cancers and disorders (40 papers), CAR-T cell therapy research (29 papers), Polyomavirus and related diseases (27 papers), Lymphoma Diagnosis and Treatment (25 papers), Immune Cell Function and Interaction (21 papers) and Virus-based gene therapy research (20 papers). The work is most often cited by research in Hematology (793 citations), Immunology (1.0k citations), Genetics (493 citations), Oncology (1.0k citations) and Transplantation (66 citations). Susan E. Prockop has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Howard T. Petrie, Richard J. O’Reilly, Evan Lind, Guenther Koehne, Farid Boulad, Nancy A. Kernan, Aisha Hasan, Jason Plotkin, Ana Paula Lepique and Ekaterina Doubrovina. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Cytotherapy, Transplantation and Cellular Therapy and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact